Progressive Muskeldystrophien und kongenitale Myopathien

Living reference work entry
First Online:
Received:
Accepted:
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Muskeldystrophien sind eine klinisch und pathogenetisch heterogene Gruppe progressiver Muskelerkrankungen, die zu einer primären Degeneration von Muskelfasern führen. Das Manifestationsalter reicht von der frühen Kindheit bis in das späte Erwachsenenalter. Bei vielen Formen ist der zugrunde liegende Gendefekt bekannt, und es erfolgt eine genetische Klassifikation. Auch die kongenitalen Myopathien, die bereits kurz nach der Geburt klinisch manifest werden, stellen mittlerweile eine große Gruppe von Myopathien dar.

This is a preview of subscription content, log in to check access

Literatur

  1. Blumen SC, Bouchard JP, Brais B et al (2009) Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology 73:596–601CrossRefGoogle Scholar
  2. Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, Orcesi S, Lanzi G, Angelini C (2000) A multicenter, double-blind, randomized, trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23:1344–1347CrossRefGoogle Scholar
  3. Brais B, Bouchard JP, Xie YG et al (1998) Short GCG expansion in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167CrossRefGoogle Scholar
  4. Bushby K, Finkel R, Birnkrant DJ et al (2010a) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93CrossRefGoogle Scholar
  5. Bushby K, Finkel R, Birnkrant DJ et al (2010b) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177–189CrossRefGoogle Scholar
  6. Davies JE, Wang L, Garcia-Oroz L et al (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11:672–677CrossRefGoogle Scholar
  7. Davies JE, Sarkar S, Rubinsztein DC (2006) Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet 15:23–31CrossRefGoogle Scholar
  8. De Sandre-Giovannoli A, Chaouch M, Kozlov S et al (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot–Marie–Tooth disorder type 2) and mouse. Am J Hum Genet 70:726–736CrossRefGoogle Scholar
  9. Deschauer M, Pushpa RJ, Gläser D, Hanisch F, Stoltenburg G, Zierz S (2011) Klinische und molekulargenetische Befunde der Muskeldystrophie mit Anoctamin 5-Mutationen. Nervenarzt 82:1596–1603CrossRefGoogle Scholar
  10. Eger K, Jordan B, Habermann S, Zierz S (2010) Beevor’s sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. J Neurol 257:436–438CrossRefGoogle Scholar
  11. Feit H, Silbergleit A, Schneider L et al (1998) Vocal cord and pharyngeal weakness with autosomal distal myopathy: clinical description and gene localization to chromosome 5q31. Am J Hum Genet 63:1732–1744CrossRefGoogle Scholar
  12. Fischer D, Walter MC, Kesper K et al (2005) Diagnostic value ot muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252:538–547CrossRefGoogle Scholar
  13. Gaul C, Deschauer M, Tempelmann C et al (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I (LGMD2I) – conventional cardiac diagnostic and cardiovascular magnetic resonance (CMR. J Neurol 253:1317–1322CrossRefGoogle Scholar
  14. Guglieri M, Straub V, Bushby K, Lochmüller H (2008) Limb-girdle muscular dystrophies. Curr Opin Neurol 21:576–584CrossRefGoogle Scholar
  15. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B (2002) Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 71:492–500CrossRefGoogle Scholar
  16. Hanisch F, Grimm D, Zierz S, Deschauer M (2010) Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and limb girdle muscular dystrophy type 2 in German patients. J Neurol 257:300–301CrossRefGoogle Scholar
  17. Hassan A, Jones LK, Milone M, Kumar N (2012) Focal and other unusual presentations of facioscapulohumeral muscular dystrophy. Muscle Nerve 46:421–425CrossRefGoogle Scholar
  18. Hicks D, Sarkozy A, Muelas N et al (2011) A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain 134:171–182CrossRefGoogle Scholar
  19. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, Palmer J, Gallano P, Baiget M, Matsuda C, Brown RH Jr (2001) Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49:130–134CrossRefGoogle Scholar
  20. Krasnianski M, Neudecker S, Eger K, Schulte-Mattler W, Zierz S (2003a) Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes. Nervenarzt 74:151–158CrossRefGoogle Scholar
  21. Krasnianski M, Neudecker S, Eger K, Jakubiczka S, Zierz S (2003b) Atypical phenotypes in patients with FSHD 4q35 deletion. Arch Neurol 60:1421–1425CrossRefGoogle Scholar
  22. Kuhn M, Gläser D, Joshi PR, Zierz S, Wenninger S, Schoser B, Deschauer M (2016) Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy. J Neurol 263:743–750CrossRefGoogle Scholar
  23. Larsen M, Rost S, Kress W, El Hajj N, Ferbert A, Deschauer M, Walter MC, Tacik P, Müller CR (2015) Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 23:808–816CrossRefGoogle Scholar
  24. Lemmers RJ, van der VP, Klooster R et al (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650–1653CrossRefGoogle Scholar
  25. Lemmers RJ, O’Shea S, Padberg GW et al (2012a) Best practice guidelines in genetic diagnostics of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 22:463–470CrossRefGoogle Scholar
  26. Lemmers RJ, Tawil R, Petek LM et al (2012b) Digenic inhetiance o fan SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44:1370–1374CrossRefGoogle Scholar
  27. Liang WC, Mitsuhashi H, Keduka E, Nonaka I, Noguchi S, Nishino I, Hayashi YK (2011) TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol 69(6):1005–1013CrossRefGoogle Scholar
  28. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH Jr (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31–36CrossRefGoogle Scholar
  29. Markesbery WR, Griggs RC, Leach RP, Lapham LW (1974) Related articles. Late onset hereditary distal myopathy. Neurology 24:127–134CrossRefGoogle Scholar
  30. Meredith C, Herrmann R, Parry C et al (2004) Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet 75:703–708CrossRefGoogle Scholar
  31. Merideth MA, Gordon LB, Clauss S et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604Google Scholar
  32. Mueller TJ, Kraya T, Stoltenburg G, Stock K, Deschauer M, Zierz S (2010) Matrin3-myopathy: distal and axial myopathy without vocal cord involvement. Clin Neurophysiol 121(Suppl 1):S306–S307CrossRefGoogle Scholar
  33. Müller T, Schröder R, Zierz S (2001) GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Muscle Nerve 24:120–122CrossRefGoogle Scholar
  34. Müller T, Krasnianski M, Witthaut R, Deschauer M, Zierz S (2005) Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Neuromuscul Disord 15:372–376CrossRefGoogle Scholar
  35. Müller T, Deschauer M, Kolbe-Fehr F, Zierz S (2006) Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy. J Neurol 253:892–895CrossRefGoogle Scholar
  36. Nguyen K, Bassez G, Krahn M et al (2007) Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 64:1176–1182CrossRefGoogle Scholar
  37. Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33:1–12PubMedPubMedCentralGoogle Scholar
  38. Nonaka I, Sunohara N, Ishiura S, Satoyoshi E (1981) Familial distal myopathy with rimmed vacuoles and lamellar (myeloid) body formation. J Neurol Sci 51:141–151CrossRefGoogle Scholar
  39. Norwood F, de Visser M, Eymard B, EFNS Guideline Task Force et al (2007) EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol 14:1305–1312CrossRefGoogle Scholar
  40. Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132:3175–3186CrossRefGoogle Scholar
  41. Quijano-Roy S, Mbieleu B, Bonnemann CG et al (2008) De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 64:177–186CrossRefGoogle Scholar
  42. Sarkozy A, Deschauer M, Schrank B et al (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 22:S122–S129CrossRefGoogle Scholar
  43. Selcen D, Engel AG (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57:269–276CrossRefGoogle Scholar
  44. Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, Elbracht M, Stendel C, Tournev I, Mihailova V, Feit H, Tramonte J, Hedera P, Crooks K, Bergmann C, Rudnik-Schöneborn S, Zerres K, Lochmüller H, Seboun E, Weis J, Beckmann JS, Hauser MA, Jackson CE (2009) Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 84:511–518CrossRefGoogle Scholar
  45. Tomimitsu H, Shimizu J, Ishikawa K, Ohkoshi N, Kanazawa I, Mizusawa H (2004) Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant. Neurology 62:1607–1610CrossRefGoogle Scholar
  46. Udd B (2007) Molecular biology of distal muscular dystrophies – sarcomeric proteins on top. Biochim Biophys Acta 1772:145–158CrossRefGoogle Scholar
  47. Udd B, Kaarianen H, Somer H (1991) Muscular dystrophy with separate clinical phenotypes in a large family. Muscle Nerve 14:1050–1058CrossRefGoogle Scholar
  48. Udd B, Partanen J, Halonen P, Falck B, Hakamies L, Heikkila H, Ingo S, Kalimo H, Kaariainen H, Laulumaa V et al (1993) Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients. Arch Neurol 50:604–608CrossRefGoogle Scholar
  49. Udd B, Vihola A, Sarparanta J, Richard I, Hackman P (2005) Related articles. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 64:636–642CrossRefGoogle Scholar
  50. Vissing J (2016) Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies. Curr Opin Neurol 29:635–641CrossRefGoogle Scholar
  51. Walter MC, Petersen JA, Stucka R et al (2004) FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 41:e50CrossRefGoogle Scholar
  52. Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Müller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochmüller H (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8:26CrossRefGoogle Scholar
  53. Wang CH, Leung M, Liang WC et al (2012) Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 22:331–338CrossRefGoogle Scholar
  54. Zierz SF (2013) Muskelerkrankungen. Thieme, Stuttgart/New YorkGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  1. 1.Klinik und Poliklinik für NeurologieMartin-Luther-Universität Halle-WittenbergHalleDeutschland
  2. 2.Neurologische Klinik und PoliklinikTechnische Universität MünchenMünchenDeutschland

Personalised recommendations